Journal Menu
► ▼ Journal Menu-
- Genes Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
20 May 2026
Genes Webinar | Genomic and Molecular Determinants of HPV-Related Reproductive Health, 3 June 2026
Join us for an insightful webinar exploring the latest advances in HPV (Human Papillomavirus) research and their impact on precision medicine and reproductive health. We will discuss breakthroughs in viral genomics, updates on HPV vaccination, and recent legislative developments shaping prevention and public health strategies.
This session brings together experts to highlight how cutting‑edge science is transforming HPV screening, treatment, and long‑term disease prevention.
Date: 3 June 2026
Time: 3:00 p.m. CEST | 9:00 a.m. EDT | 9:00 p.m. CST Asia
Webinar ID: 810 5797 3441
Website: https://sciforum.net/event/Genes-5?subscribe
Register now for free!
Program:
| Speaker/Presentation | Time in CEST | Time in EDT |
| MDPI Host – Robert Stefan Feurdean Genes Journal Introduction |
3:00–3:05 p.m. | 9:00–9:05 a.m. |
| Dr. Nektaria Zagorianakou Webinar Opening and Special Issue Introduction |
3:05–3:10 p.m. | 9:05–9:10 a.m. |
| Dr. Nektaria Zagorianakou HPV Vaccination: Evolution, Evidence, and Clinical Impact |
3:10–3:30 p.m. | 9:10–9:30 a.m. |
| Prof. Georgios Makrydimas HPV in Pregnancy: Clinical Implications and Management |
3:30–3:50 p.m. | 9:30–9:50 a.m. |
| Prof. Ioannis Georgiou Genomic Alterations Caused by HPV Integration |
3:50–4:10 p.m. | 9:50–10:10 a.m. |
| Dr. Efthalia Moustakli HPV-Induced Redox Reprogramming: Are Extracellular Vesicles the Missing Link? |
4:10–4:30 p.m. | 10:10–10:30 a.m. |
| Q&A Session | 4:30–4:45 p.m. | 10:30–10:45 a.m. |
| Dr. Nektaria Zagorianakou Closing of Webinar |
4:45–4:50 p.m. | 10:45–10:50 a.m. |
After registering, you will receive a confirmation email outlining how to join this webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Speaker:
- Dr. Nektaria Zagorianakou, Department of Nursing, School of Health Sciences, University of Ioannina, Greece.
Speakers:
- Prof. Georgios Makrydimas, Department of Obstetrics and Gynecology, University of Ioannina, Greece;
- Prof. Ioannis Georgiou, Department of Obstetrics and Gynecology, University of Ioannina, Greece;
- Dr. Efthalia Moustakli, Department of Nursing, School of Health Sciences, University of Ioannina, Greece.
Relevant Special Issues:
“Genomic and Molecular Determinants of HPV-Related Reproductive Health”
Guest Editors: Dr. Nektaria Zagorianakou and Dr. Efthalia Moustakli
Deadline for manuscript submissions: 15 August 2026
8 May 2026
Meet Us at the National Congress of Plant Biology 2026, 6–10 November 2026, Hangzhou, China
Conference: National Congress of Plant Biology 2026
Organization: Chinese Society for Plant Biology
Date: 6–10 November 2026
Place: Hangzhou, China
With the vigorous development of plant science in China over the past fifteen years, the National Congress of Plant Biology has been continuously strengthened in terms of organizational scale and influence and has become the largest event in the field of plant science in China.
This conference covers topics including plant metabolism and synthesis, cell and development, genetics and genome, light signaling and photosynthesis, evolution and conservation, molecular breeding, plant–microbe interactions, abiotic stress biology, interdisciplinary studies and AI design, and smart agriculture. The conference will also feature a special forum on youth development and journal development, a graduate student forum, and a poster fund. These initiatives aim to foster new academic growth points, promote interdisciplinary integration and industry–academia research collaboration, strengthen the training of young talents, and encourage plant biology researchers to reach new academic heights, thus injecting momentum into the development of plant biology in China and internationally.
The following MDPI journals will be represented:
- Plants;
- International Journal of Molecular Sciences (IJMS);
- Biomolecules;
- Life;
- Stresses;
- Epigenomes;
- International Journal of Plant Biology (IJPB);
- AgriEngineering;
- Genes;
- Agronomy;
- Phycology.
If you attend this conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
7 May 2026
Meet Us at the ASHG 2026 Annual Meeting, 20–24 October 2026, Montréal, Canada
Conference: ASHG 2026 Annual Meeting
Organization: American Society of Human Genetics
Date: 20–24 October 2026
Place: Montréal, Canada
Booth: #1000
MDPI will attend the ASHG 2026 Annual Meeting, held in Montréal, Canada, from 20 to 24 October 2026.
The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.
The following MDPI journals will be represented:
- Genes;
- IJMS;
- Biomedicines;
- Vaccines;
- DNA;
- Epigenomes.
If you plan on attending this conference, please stop by our booth #1000 and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit the following website: https://meetings.ashg.org/event/EVEEGOIQACFJJ/home/.
6 May 2026
MDPI INSIGHTS: The CEO's Letter #34 - MDPI US Office, Coatings 2026, Media and Partnerships, Recapping Poland Summit & Serbia Salon
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

MDPI Opens First US Office in Philadelphia
I am delighted to highlight an important milestone in MDPI’s continued global development: the recent opening of our first office in the United States, located in Philadelphia.
This marks a significant step in building our engagement with one of the world’s most important research communities. The new office will serve as a hub for supporting scholars across the US, creating closer connections and more localized support.
As highlighted in recent coverage by our press release in InPublishing, this expansion reflects MDPI’s broader commitment to growing our international presence while remaining focused on the needs of the research community.
A Key Market for Research and Collaboration
The United States continues to play a central role in global research. To date, MDPI has published more than 237,000 articles affiliated with US institutions, and we collaborate with nearly 12,000 Editorial Board Members across the country. These relationships are fundamental to our mission of supporting Open Access and advancing scientific communication.
The opening of this office is not just about geography; it is about proximity to the communities we serve. It allows us to better understand the evolving needs of researchers while continuing to build collaboration and trust within the academic ecosystem.
The Team Behind this Milestone

This milestone reflects the efforts of teams across MDPI. I extend a special thank-you to Bob Vrooman (Head of Business Development, MDPI), who is leading this expansion, as well as to our colleagues in Toronto and across our North American teams for their continued support.
Bob shared: “MDPI is already a trusted partner of the North American research community, due in no small part to our dedicated team in Canada. Launching our first US office in Philadelphia is a great first step towards expanding MDPI’s market share and recognition in the US. I’m thrilled to be a part of this new phase in MDPI’s journey.”
As we continue to grow, our focus remains on supporting researchers globally and advancing Open Access with integrity.
Impactful Research

Coatings 2026: Highlights from Our Latest MDPI Conference (20-22 April)
I am pleased to share the successful completion of MDPI conference Coatings 2026, which took place last week in Athens from 20 to 22 April 2026. This conference brought together a diverse international community of researchers, industry experts, and partners, highlighting MDPI’s role not only as a publisher but also as a platform for scientific exchange and collaboration.
Conference Highlights
Coatings 2026 in numbers:
- The event attracted approximately 140 participants from 25 countries
- 143 submissions and a strong scientific program of talks and posters
- 2 keynote speakers and a wide range of invited contributions
- 7 sponsors and 11 media partners supporting the event
|
|
|
|
|
|
Scientific Programme
The program centered on “Safe and Sustainable by Design,” reflecting the growing importance of sustainability, regulatory frameworks, and technological innovation in materials science. Topics ranged from advanced coating technologies and additive manufacturing to AI-driven simulations and strategies to phase out potentially harmful substances in industrial processes.
Importantly, the conference brought together both academic and industrial perspectives, creating a space for dialogue on how research can translate into real-world impact. This is important as industries navigate environmental challenges, evolving regulations, and the need for more sustainable and circular approaches to production.
Thank You!
I would like to thank the entire conference team for their work in organizing this successful event. As we continue to grow, conferences like this play an important role in building our connection with global research communities, supporting interdisciplinary collaboration, and positioning MDPI at the intersection of science, technology, and societal impact.
Members from Exelisis and MDPI EU Conference & Social Media team at the Coatings 2026 Conference in Athens, Greece.
Inside MDPI

Recent Media Coverage and Partnerships
Over the past two months, news from MDPI has enjoyed strong visibility across international publishing and academic media, reflecting our continued expansion and the increasing relevance of our work within the research community.
Below are some highlights covering partnerships, institutional agreements, and milestones that continue to shape our position in publishing – some of which are featured in leading industry platforms such as InPublishing, which is highly selective and reflects the growing recognition of MDPI’s growth within the publishing ecosystem.
Key Press Releases & Coverage (March–April 2026)
-
MDPI × Sikt (Norway): Partnership Renewal
We renewed our national Open Access agreement with Sikt, a key consortium partnership, continuing to support researchers across Norway through this partnership. The renewal was covered by several international publishing trade outlets.
Covered by: Research Information, STM Publishing News, ALPSP, Europe Says
-
MDPI × Jisc (UK): New Two-Year Open Access Agreement
A new two-year agreement with Jisc significantly expands MDPI’s footprint across UK academic institutions. Coverage appeared across major publishing industry titles in the UK and internationally.
Covered by: InPublishing, Research Information, STM Publishing News, ALPSP
-
MDPI Opens First US Office
The opening of our first US office marks an important milestone in our North American expansion to build engagement with one of the world’s leading research communities.
Coverage by: EurekAlert!, InPublishing, EdTech Innovation Hub, STM Publishing News, ALPSP
-
MDPI × SIGG: Italian Society of Gerontology and Geriatrics
We established a new partnership with the Italian Society of Gerontology and Geriatrics (SIGG), adding to our growing portfolio of society collaborations.
Coverage by: EurekAlert!, STM Publishing News, ALPSP
-
MDPI × Fast Track Health: New Journal Launch
The launch of a new journal in partnership with Fast Track Health reflects our continued expansion into emerging areas of health innovation.
Coverage by: EurekAlert!, Scienmag, STM Publishing News, ALPSP
-
MDPI 2025 Annual Report
Our 2025 Annual Report was also widely covered across international media, highlighting a 12% increase in submissions and continued investment in research integrity, infrastructure, and partnerships.
Coverage by: EurekAlert!, Research Information, STM Publishing News, ALPSP, Choice 360
Coverage also spanned multiple regions including Poland, Romania and South Korea, reflecting our ongoing efforts to communicate more effectively with regional research communities.
Looking Ahead
This coverage shows that MDPI is growing and building on its position through partnerships, visibility, and engagement across regions. As we continue to expand, our focus remains on supporting researchers globally, building on our institutional collaborations, and advancing Open Access with integrity.
Thank you to all teams involved in delivering these initiatives, and to our External Affairs team for ensuring our work is effectively communicated across the global publishing landscape!
Coming Together for Science

Recapping MDPI Poland Summit 2026 in Krakow (23 April)
On 23 April 2206, we hosted the first MDPI Poland Summit 2026 in Kraków, bringing together an engaged group of editors, researchers, and academic leaders from the country.
The Poland Summit welcomed some 45 participants, including Editors-in-Chief, Associate Editors, and Editorial Board Members, many with strong academic track records and international recognition.
Our engagements were open and constructive, focusing on MDPI’s positioning and reputation in Poland, alongside community interest in supporting our development, with active participation across our sessions, including Q&A and panel discussions.
|
|
|
|
MDPI Poland Summit Programme
From research integrity and peer review quality to AI in publishing and the future of academic communication, the agenda featured important topics currently shaping our industry.
During the day, MDPI colleagues shared a series of presentations covering:
- MDPI’s performance, growth, and impact in Poland: Stefan Tochev (CEO)
- Engagement with Academic Community: Dr. Marta Colomer (Public Affairs Lead)
- Research Integrity and Publication Ethics: Anna Pena (Research Integrity Manager)
- MDPI Editorial Process and Peer-Review Quality Metrics: Dr. Liliane Auwerter (Conference Organizer)
- AI in the Publishing Industry – Challenges, Innovation and MDPI’s vision: Dr. Enric Sayas (AI Product Owner)
- Panel Session: The Future of Academic Publishing, moderated by Dr. Marta Colomer
|
|
|
|
|
|
|
|
Poland as a Key Market for Open Access
The summit also highlighted the importance of Poland within the global research landscape.
In 2025:
- 75% of publications in Poland were made in Open Access
- 71% of those in Gold Open Access
- and over 344,000 publications produced in the last five years
MDPI plays a significant role in the Polish publishing ecosystem:
- #1 Open Access publisher in Poland
- 17% share of Open Access publications in 2025
- More than 12,500 publications from Polish institutions in 2025
- More than 91,000 publications overall since 1996
Looking Ahead
Events like the Poland Summit are an important part of how we evolve as an organization. They allow us to share the latest developments of MDPI and listen directly to our researchers and editors to better understand the market and align our development with the needs of the local community.
As MDPI continues to grow, this type of engagement will remain essential in ensuring that we are not only scaling globally, but doing so in a way that is aligned, trusted, and collaborative.

With Igor Matic (Office Manager, Krakow, Poland, MDPI) at the MDPI Poland Summit in Krakow.
Closing Thoughts

Recapping MDPI Serbia Salon 2026 in Belgrade (22 April)
On 22 April 2026, we hosted the MDPI Serbia Salon 2026 in Belgrade. The Salon welcomed over 50 participants, including more than 40 invited scholars from leading Serbian institutions, alongside colleagues from MDPI. The event also marked two important milestones: 30 years of MDPI and 10 years of our presence in Serbia, making it a celebration and an opportunity for reflection.

A Platform for Exchange
The Salon was designed not just as a series of presentations, but as a place for dialogue. Throughout the day, discussions focused on important topics around publishing today: research integrity and editorial standards, journal indexing and visibility, the evolving role of artificial intelligence, and funding and support for Open Access publishing.
|
|
|
|
|
|
|
|
Program Overview
- Opening the Salon MDPI Serbia 2026 – Serbia results and direction: Emir Ramadani (Operations Manager)
- Update on MDPI’s performance and growth: Stefan Tochev (CEO)
- Collaboration with MDPI – A personal perspective: Prof. Dr Srećko Stopić (Editorial Board Member)
- Linking Scientific Quality and Visibility: The role of indexing in publishing
- Research integrity and editorial ethics: Ana Stanković (Research Integrity Specialist)
- Artificial Intelligence in Scientific Publishing – Challenges, innovations and vision of MDPI: Dr Miloš Čučulović (Head of Technology Innovation)
It was encouraging to see the high level of engagement and discussion with the local academic community.
|
|
|
|
|
|
|
|
Publishing in Serbia
With 10 years of MDPI in Serbia (since 2016) and over 620 colleagues across 10 departments spread across offices in Belgrade and Novi Sad, MDPI continues to invest in the long-term development of the research community in Serbia and beyond.
Some high-level indicators illustrate both the strength of the local research ecosystem and MDPI’s role within it:
- 12,910 total publications in Serbia in 2025, of which 8,708 (67%) were Open Access (of which, in turn, 75% were Gold OA)
- A total of more than 55,000 publications (2021–2025), with 68% published Open Access
- 2,122 MDPI publications from Serbian institutions in 2025
- 25% of all Open Access publications in Serbia are published with MDPI
- More than 11,000 MDPI publications from Serbian institutions since 1996
- More than 75 Editorial Board Members from Serbia, including Editors-in-Chief and Associate Editors.
These figures reflect the growth of OA publishing in Serbia and the strong collaboration between MDPI and Serbia's research community.
Top 5 Publishers in Serbia (MDPI #1 with steady growth)

Looking Ahead
Research integrity and artificial intelligence will remain central topics for the industry. At the same time, clear communication of editorial processes will be essential in building trust and transparency.
Workshops and direct engagement remain among the most effective ways to strengthen these connections. As Open Access funding models continue to evolve, new opportunities for collaboration are emerging across institutions, publishers, and the broader research community.
Thank You!
The excellent feedback from participants shows the value of creating spaces where ideas can be exchanged openly and constructively. Sincere thanks to everyone who contributed to the success of this event: our speakers, participants, and especially the MDPI Serbia team for their great organization and support.

Chief Executive Officer
MDPI AG
24 April 2026
Prof. Dr. William Gerwick Appointed Chair of the 2026 Tu Youyou Award Committee
We are honored to announce that Prof. Dr. William Gerwick will serve as the Chair of the 2026 Tu Youyou Award Committee.
A world-renowned authority in marine natural products chemistry and pharmacology, Professor Gerwick is a Distinguished Professor at both the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). His pioneering work at the intersection of ocean sciences and drug discovery makes him a fitting leader for an award centered on transformative medicinal breakthroughs.
Under Professor Gerwick’s stewardship, the 2026 Tu Youyou Award Committee will focus on recognizing innovative and impactful research in natural products chemistry and medicinal chemistry, particularly work with the potential to drive meaningful advances in both scientific understanding and human health.
To provide further insight into his perspectives, we include below an interview with Professor Gerwick, in which he reflects on his scientific journey, his views on the field, and his vision for the Tu Youyou Award.
A Conversation with the Chair
1. Could you please introduce yourself and your research journey?
My research focuses on the natural products of marine algae and cyanobacteria, their application in medicine, their biosynthesis using genomic approaches, and innovative methods in the structure elucidation of natural products.
I received my BS degree from the University of California at Davis, my PhD from the University of California at San Diego, and conducted postdoctoral work at the University of Connecticut. After a couple of years in a junior faculty position at the Department of Chemistry at the University of Puerto Rico, I spent 21 years as Professor of Pharmacy at Oregon State University. In 2005, I returned to my PhD institution at the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, where I am currently a Distinguished Professor of Oceanography and Pharmaceutical Sciences.
Throughout my career, I have been dedicated to advancing the field through both leadership and mentorship. I have served as president of the American Society of Pharmacognosy, chaired and co-chaired several major research conferences, and served as an associate editor for the Journal of Natural Products. I am a Fellow of the American Association for the Advancement of Science (AAAS) and of the American Society of Pharmacognosy. I have trained over 100 doctoral and postdoctoral students, and my research group has published nearly 500 papers and more than 25 patents on topics in the natural product sciences and medicinal chemistry.
2. What motivated you to accept the role of Chair of the 2026 Tu Youyou Award Committee?
Of course, I am a huge supporter of all awards that are given in recognition of excellent scientific research, and especially so in the natural products sciences and medicinal chemistry. However, this award is truly special in that it recognizes scientific excellence as well as impact, and is given in the name of an individual, Tu Youyou, who clearly had many challenges along the path to reach the pinnacle of her success. Not only was she the first Chinese person to win a Nobel prize in this area, but she was also the first Chinese woman to receive a Nobel prize, and this was achieved without graduate education in China or elsewhere. It’s a true testament to what can be achieved by hard work, determination, and vision. To read the history of her extraordinary approach to discovering novel antimalarial compounds from Traditional Chinese Medicine is truly inspirational. It is, therefore, the inspiration provided by the extraordinary life and career of Tu Youyou that motivated me to accept the Chair of the Award Committee for 2026.
3. How do you view the role of natural products chemistry and medicinal chemistry in today’s scientific landscape, and what major advances over the past decade have shaped this field?
A quite remarkable integration of fields is currently transforming natural products science and medicinal chemistry. In natural products, we are seeing integration of different omics methods, from metabolites to proteins to nucleic acids. Sophisticated biological and pharmacological approaches are driving the discovery of exquisitely potent and selective natural products. Advances are being made to integrate molecular-level recognition of natural products with chemical ecological studies, and sophisticated methods of structure determination using Artificial Intelligence or pioneering new tools such as microED are being applied with increasing frequency. High-level synthetic methodologies, such as protecting group-free synthetic routes, are enhancing medicinal chemistry, accelerating the identification of lead molecules with attractive pharmaceutical properties at an increasing pace.
4. How do you consider the balance between fundamental discovery (e.g., new molecules or mechanisms) and practical impact (e.g., therapeutic applications)?
Many individuals are excellent scientists and mentors, and have essential roles in developing our culture that values science and the scientific method. It should also be pointed out that not all scientific discoveries are going to have a broad societal impact, but they are nevertheless critical to the overall body and structure of science. But it is a truly remarkable individual who makes a key scientific discovery, recognizes its potential value to society in general, and then has the skills and determination to bring it forward as a useful product. That was the type of person the Tu Youyou is, and that is the type of person who is honored by the prize in her name.
5. What do you see as the key challenges or opportunities currently facing the field?
We are on the crux of an amazing revolution in many of the sciences, including natural products and medicinal chemistry; the purposeful application of Artificial Intelligence to solving many of the difficulties involved in the search for new pharmaceuticals from Nature. AI is transforming how we select organisms for study, what pharmaceutical targets to go after, rapidly resolving the chemical structures of new compounds, identifying efficient routes to their chemical synthesis, understanding their molecular mechanisms of action, and finally, designing their clinical application. The role of people in these pursuits is changing. Increasingly, the human role will be providing overall vision: what can we do? What should we do? And it is important to remember that AI is providing hypotheses, not truth. Scientists with expert domain knowledge will be critical for discerning the correctness of hypotheses put forth by AI. Altogether, advances in technology, expanding knowledge, and the appropriate use of AI methods are preparing society to be able to address emerging diseases, such as pandemics, as well as conditions that are not effectively treated by currently existing therapeutics.
6. How do you expect the Tu Youyou Award to contribute to the advancement of natural product chemistry, medicinal chemistry, and human health over the coming years?
The Tu Youyou Award is potentially transformative for the broad fields of natural products science and medicinal chemistry as it brings a significantly increased level of visibility to these topics and their contributions to human health. It will be crucial to have excellent communication to news agencies, social media and other communication outlets so that the general public is informed and educated on the high impact of these natural product/medicinal chemistry contributions. This will bring increased funding, attract promising students, and generally enrich the interface of these fields with the health sector.
7. What message would you like to convey to the research community and the public during this open nomination phase?
This prize gives broad societal visibility to the role that natural products have had in shaping a majority of our current medicines, as well as understanding the life forms with whom we share the planet. Further, it recognizes a woman scientist working under sub-optimal conditions who could persevere and make discoveries of global impact. The prize and what it represents, therefore, inspires current and future generations to engage in the study of Nature and its relationship to Human Health, to overcome adversity, and to aspire to making one’s life impactful.
About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal and a certificate.
The 2026 Tu Youyou Award is open for nominations until 31 October 2026. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.
If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.
16 April 2026
MDPI’s Newly Launched Journals in the First Quarter of 2026
Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In the first quarter of 2026, nine new journals released their inaugural issues and three transferred journals released their first issue as part of MDPI, covering the subjects of clinical medicine, chemistry, computer science & mathematics, engineering, environment & ecology, and social sciences & psychology.
We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these brand-new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
New Journals |
Founding Editor(s)-in-Chief |
Journal Topics (Selected) |
|
Prof. Dr. Matt Oehlschlaeger, |
AI-based chemical data analysis, prediction, and discovery; AI-enabled chemical reaction prediction, synthesis planning, and retrosynthesis; AI in bioorganic chemistry and chemical biology; digital twins and simulation of chemical processes; AI-powered chemical education and pedagogy | |
|
|
Prof. Dr. Guang Jia, |
occupational hazards and exposure science; occupational health effects and susceptibility; occupational risk assessment and management; occupational health intervention, promotion, and policy | |
|
|
Prof. Dr. Alessandro Miani, |
environmental exposures and health; the built environment and public health; One Health approach; environmental justice and health equity; environmental policies and interventions | |
|
|
Prof. Dr. Miriam H. A. Bopp, |
neuroimaging technology and tool; multimodal neuroimaging integration and analysis; |
|
|
Prof. Dr. Raul A. Urrutia, |
personalized translational and clinical oncology research that contribute to a deeper understanding of cancer diagnoses, prognoses, prevention, and treatment specifically for individual patients | |
|
|
Prof. Dr. Pierre Boulanger, |
AI in disease detection, diagnosis, prediction, and treatment; medical informatics; AI in genomics and precision medicine; AI in drug discovery and development; |
|
|
Prof. Dr. Zhaokui Wang, |
astrodynamics; spacecraft technology; satellite technology; space transportation; space vehicle design, propulsion, and avionics; space energy, power and propulsion | |
|
|
Prof. Dr. Richard J Hauer, |
park design, planning, and evaluation; park and art; park, industrialization, urbanization, and civilization; park and education; park and smart society; park role in SDGs; park services for humans | |
|
|
Prof. Dr. Stacey L. Connaughton, |
conflict resolution; peacebuilding; peacemaking; mediation, reconciliation, and transitional justice; sustaining peace | |
|
Transferred Journals |
Editor(s)-in-Chief |
Journal Topics (Selected) |
|
Prof. Dr. Gianluigi Vendemiale, |
physiology and pathology of aging; biogerontology; epidemiology; clinical geriatrics; pharmacology; geriatric nursing | |
|
|
Prof. Dr. Michele Maffia, |
cellular and developmental biology; physiology, pathophysiology and endocrinology; diagnostic tools, therapies and public health | |
|
|
Dr. Warren S. Joseph, |
foot and ankle medicine; podiatric medicine | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).
10 April 2026
Genes | Top Viewed Papers in 2024–2025
Genes (ISSN: 2073-4425) is an international, peer-reviewed open access journal which provides an advanced forum for studies related to genes, genetics, and genomics. For more information about the journal, please visit the following link: https://www.mdpi.com/journal/genes.
All papers are in an open-access format, granting our readers free and unlimited access to the full text of all the articles published in our journal. We welcome you to read our most top viewed papers published in 2024 and 2025, which are listed below.
1. “A Comprehensive Review of Bioinformatics Tools for Genomic Biomarker Discovery Driving Precision Oncology”
by Alexis J. Clark and James W. Lillard, Jr.
Genes 2024, 15(8), 1036. https://doi.org/10.3390/genes15081036
Available online: https://www.mdpi.com/2073-4425/15/8/1036
2. “Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing”
by Valeria Barili, Enrico Ambrosini, Beatrice Bortesi, Roberta Minari, Erika De Sensi, Ilenia Rita Cannizzaro, Antonietta Taiani, Maria Michiara, Angelica Sikokis, Daniela Boggiani et al.
Genes 2024, 15(2), 219; https://doi.org/10.3390/genes15020219
Available online: https://www.mdpi.com/2073-4425/15/2/219
3. “Beyond the Anticodon: tRNA Core Modifications and Their Impact on Structure, Translation and Stress Adaptation”
by Marcel-Joseph Yared, Agathe Marcelot and Pierre Barraud
Genes 2024, 15(3), 374; https://doi.org/10.3390/genes15030374
Available online: https://doi.org/10.3390/genes15030374
4. “Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome”
by Alejandro Borrego-Ruiz and Juan J. Borrego
Genes 2024, 15(12), 1599; https://doi.org/10.3390/genes15121599
Available online: https://doi.org/10.3390/genes15121599
5. “Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors”
by Francesca Cillo, Emma Coppola, Federico Habetswallner, Francesco Cecere, Laura Pignata, Elisabetta Toriello, Antonio De Rosa, Laura Grilli, Antonio Ammendola, Paolo Salerno et al.
Genes 2024, 15(3), 321; https://doi.org/10.3390/genes15030321
Available online: https://doi.org/10.3390/genes15030321
6. “HERVs: Expression Control Mechanisms and Interactions in Diseases and Human Immunodeficiency Virus Infection”
by Federica Mantovani, Konstantina Kitsou and Gkikas Magiorkinis
Genes 2024, 15(2), 192; https://doi.org/10.3390/genes15020192
Available online: https://doi.org/10.3390/genes15020192
7. “Karyotype Diversification and Chromosome Rearrangements in Squamate Reptiles”
by Marcello Mezzasalma, Rachele Macirella, Gaetano Odierna and Elvira Brunelli
Genes 2024, 15(3), 371; https://doi.org/10.3390/genes15030371
Available online: https://doi.org/10.3390/genes15030371
8. “Hypoxia in the Blue Mussel Mytilus chilensis Induces a Transcriptome Shift Associated with Endoplasmic Reticulum Stress, Metabolism, and Immune Response”
by Milton Montúfar-Romero, Valentina Valenzuela-Muñoz, Diego Valenzuela-Miranda and Cristian Gallardo-Escárate
Genes 2024, 15(6), 658; https://doi.org/10.3390/genes15060658
Available online: https://doi.org/10.3390/genes15060658
9. “A Comparison of Structural Variant Calling from Short-Read and Nanopore-Based Whole-Genome Sequencing Using Optical Genome Mapping as a Benchmark”
by Yang Pei, Melanie Tanguy, Adam Giess, Abhijit Dixit, Louise C. Wilson, Richard J. Gibbons, Stephen R. F. Twigg, Greg Elgar and Andrew O. M. Wilkie
Genes 2024, 15(7), 925; https://doi.org/10.3390/genes15070925
Available online: https://doi.org/10.3390/genes15070925
10. “The Effect of Maternal Diet and Physical Activity on the Epigenome of the Offspring”
by Anastasia Panagiotidou, Christos Chatzakis, Athina Ververi, Makarios Eleftheriades and Alexandros Sotiriadis
Genes 2024, 15(1), 76; https://doi.org/10.3390/genes15010076
Available online: https://doi.org/10.3390/genes15010076
11. “Autism Spectrum Disorder: Genetic Mechanisms and Inheritance Patterns”
by Ilaria La Monica, Maria Rosaria Di Iorio, Antonia Sica, Francesca Rufino, Chiara Sotira,
Lucio Pastore and Barbara Lombardo
Genes 2025, 16(5), 478; https://doi.org/10.3390/genes16050478
Available online: https://doi.org/10.3390/genes16050478
12. “Systematic Review: Fragile X Syndrome Across the Lifespan with a Focus on Genetics, Neurodevelopmental, Behavioral and Psychiatric Associations”
by Ann C. Genovese and Merlin G. Butler
Genes 2025, 16(2), 149; https://doi.org/10.3390/genes16020149
Available online: https://doi.org/10.3390/genes16020149
13. “Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases”
by Zheng Liu and Si-Yuan Song
Genes 2025, 16(2), 135; https://doi.org/10.3390/genes16020135
Available online: https://doi.org/10.3390/genes16020135
14. “Impact of Heavy Metal and Resistance Genes on Antimicrobial Resistance: Ecological and Public Health Implications”
by Carlos G. Sánchez-Corona, Luis Uriel Gonzalez-Avila, Cecilia Hernández-Cortez, Jorge Rojas-Vargas, Graciela Castro-Escarpulli and Hugo G. Castelán-Sánchez
Genes 2025, 16(6), 625; https://doi.org/10.3390/genes16060625
Available online: https://doi.org/10.3390/genes16060625
15. “Comparative Analysis of the Genetic Composition of Minorities in the Carpathian Basin Through Genome-Wide Autosomal Data”
by András Szabó, Katalin Sümegi, Zsolt Bánfai, Kinga Hadzsiev, Ferenc Gallyas, Attila Miseta, Miklós Kásler and Béla Melegh
Genes 2025, 16(5), 607; https://doi.org/10.3390/genes16050607
Available online: https://doi.org/10.3390/genes16050607
16. “Endogenous Retroviruses in Host-Virus Coevolution: From Genomic Domestication to Functional Innovation”
by Ruqi Jiang, Jingjun Zhou, Yue Liu, Guanjin Zhou, Dongdong Fan, Lixin Xiang, Ye Chen
and Jianzhong Shao
Genes 2025, 16(8), 964; https://doi.org/10.3390/genes16080964
Available online: https://doi.org/10.3390/genes16080964
17. “Role of MicroRNAs in Acute Myeloid Leukemia”
by Aneta Wiśnik, Dariusz Jarych, Kinga Krawiec, Piotr Strzałka, Natalia Potocka,
Magdalena Czemerska, Aleksandra Sałagacka-Kubiak, Agnieszka Pluta, Agnieszka Wierzbowska
and Izabela Zawlik
Genes 2025, 16(4), 446; https://doi.org/10.3390/genes16040446
Available online: https://doi.org/10.3390/genes16040446
18. “Barth Syndrome: TAFAZZIN Gene, Cardiologic Aspects, and Mitochondrial Studies—A Comprehensive Narrative Review”
by Consolato M. Sergi
Genes 2025, 16(4), 465; https://doi.org/10.3390/genes16040465
Available online: https://doi.org/10.3390/genes16040465
19. “Identification of Key Genes Associated with Overall Survival in Glioblastoma Multiforme Using TCGA RNA-Seq Expression Data”
by Lilies Handayani, Denis Chegodaev, Ray Steven and Kenji Satou
Genes 2025, 16(7), 755; https://doi.org/10.3390/genes16070755
Available online: https://doi.org/10.3390/genes16070755
20. “Role of MicroRNAs in Acute Myeloid Leukemia”
by Aneta Wiśnik, Dariusz Jarych, Kinga Krawiec, Piotr Strzałka, Natalia Potocka, Magdalena
Czemerska, Aleksandra Sałagacka-Kubiak, Agnieszka Pluta, Agnieszka Wierzbowska and Izabela
Zawlik
Genes 2025, 16(4), 446; https://doi.org/10.3390/genes16040446
Available online: https://doi.org/10.3390/genes16040446
If you are an active researcher in this field and are interested in publishing innovative research, please do not hesitate to contact the Managing Editor, Ms. Jessie Guo (jessie.guo@mdpi.com).
10 April 2026
Genes | Highly Cited Papers in 2024–2025 in the “Molecular Genetics and Genomics” Section
The “Molecular Genetics and Genomics” Section of Genes (ISSN: 2073-4425) is dedicated to publishing original, novel, and high-impact contributions pertaining to this fundamental and cutting-edge field, covering topics such as gene discovery and regulation, genome characterization, epigenetic modification, RNA biology, and the genetic basis of inherited disorders and disease mechanisms.
All papers are in an open-access format, granting our readers free and unlimited access to the full text of all the articles published in our journal. We welcome you to read our most highly cited papers published in 2024 and 2025, which are listed below.
1. “A Comprehensive Review of HER2 in Cancer Biology and Therapeutics”
by Xiaoqing Cheng
Genes 2024, 15(7), 903. https://doi.org/10.3390/genes15070903
Available online: https://www.mdpi.com/2073-4425/15/7/903
2. “miRNA as a Biomarker for the Early Detection of Colorectal Cancer”
by David Coleman and Scott Kuwada
Genes 2024, 15(3), 338. https://doi.org/10.3390/genes15030338
Available online: https://www.mdpi.com/2073-4425/15/3/338
3. “Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond”
by Lucas W. Rowe and Thomas A. Ciulla
Genes 2024, 15(6), 720. https://doi.org/10.3390/genes15060720
Available online: https://www.mdpi.com/2073-4425/15/6/720
4. “Understanding Hypertriglyceridemia: Integrating Genetic Insights”
by Mara Alves, Francisco Laranjeira and Georgina Correia-da-Silva
Genes 2024, 15(2), 190. https://doi.org/10.3390/genes15020190
Available online: https://www.mdpi.com/2073-4425/15/2/190
5. “Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges”
by Umme Sabrina Haque and Toshifumi Yokota
Genes 2024, 15(8), 999; https://doi.org/10.3390/genes15080999
Available online: https://www.mdpi.com/2073-4425/15/8/999
6. “MTHFR Gene Polymorphisms: A Single Gene with Wide-Ranging Clinical Implications—A Review”
by Antoni F. Araszkiewicz, Krzysztof Jańczak, Paweł Wójcik, Bartłomiej Białecki, Szymon Kubiak, Michał Szczechowski and Danuta Januszkiewicz-Lewandowska
Genes 2025, 16(4), 441; https://doi.org/10.3390/genes16040441
Available online: https://www.mdpi.com/2073-4425/16/4/441
7. “ADAR Therapeutics as a New Tool for Personalized Medicine”
by Matteo Bertoli, Luca La Via and Alessandro Barbon
Genes 2025, 16(1), 77; https://doi.org/10.3390/genes16010077
Available online: https://www.mdpi.com/2073-4425/16/1/77
8. “Nucleotide Excision Repair: Insights into Canonical and Emerging Functions of the Transcription/DNA Repair Factor TFIIH”
by Amélie Zachayus, Jules Loup-Forest, Vincent Cura and Arnaud Poterszman
Genes 2025, 16(2), 231; https://doi.org/10.3390/genes16020231
Available online: https://www.mdpi.com/2073-4425/16/2/231
9. “The Impact of Storage Conditions on DNA Preservation in Human Skeletal Remains: A Comparison of Freshly Excavated Samples and Those Stored for 12 Years in a Museum Depot”
by Tonja Jeromelj, Tamara Leskovar and Irena Zupanič Pajnič
Genes 2025, 16(1), 78; https://doi.org/10.3390/genes16010078
Available online: https://www.mdpi.com/2073-4425/16/1/78
10. “Gene–Diet Interactions in Diabetes Mellitus: Current Insights and the Potential of Personalized Nutrition”
by Angeliki Kapellou, Effie Salata, Dimitrios Miltiadis Vrachnos, Sevastiani Papailia and Spiros Vittas
Genes 2025, 16(5), 578; https://doi.org/10.3390/genes16050578
Available online: https://www.mdpi.com/2073-4425/16/5/578
If you are an active researcher in this field and are interested in publishing innovative research, please do not hesitate to contact the Managing Editor, Ms. Jessie Guo (jessie.guo@mdpi.com).
10 April 2026
Genes | Highly Cited Papers in 2024–2025 in the “Human Genomics and Genetic Diseases” Section
The Section “Human Genomics and Genetic Diseases” of Genes (ISSN: 2073-4425) covers all aspects of human genetics, including molecular mechanisms, disease basis, and the diagnosis and treatment of genetic disorders and cancers.
All papers are in an open-access format, granting our readers free and unlimited access to the full text of all the articles published here. We welcome you to read our highly cited papers published in 2024 and 2025:
1. “The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions”
by Alice Man, Matteo Di Scipio, Shan Grewal, Yujin Suk, Elisabetta Trinari, Resham Ejaz and Robyn Whitney
Genes 2024, 15(3), 332; https://doi.org/10.3390/genes15030332
Available online: https://www.mdpi.com/2073-4425/15/3/332
2. “Mitochondrial DNA: Inherent Complexities Relevant to Genetic Analyses”
by Tomas Ferreira and Santiago Rodriguez
Genes 2024, 15(5), 617; https://doi.org/10.3390/genes15050617
Available online: https://www.mdpi.com/2073-4425/15/5/617
3. “Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine”
by Hannah E. Snyder, Puneet Jain, Rajesh RamachandranNair, Kevin C. Jones and Robyn Whitney
Genes 2024, 15(3), 266; https://doi.org/10.3390/genes15030266
Available online: https://www.mdpi.com/2073-4425/15/3/266
4. “Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases”
by Harry Wilton-Clark, Eric Yan and Toshifumi Yokota
Genes 2024, 15(7), 821; https://doi.org/10.3390/genes15070821
Available online: https://www.mdpi.com/2073-4425/15/7/821
5. “Through the Cat-Map Gateway: A Brief History of Cataract Genetics”
by Alan Shiels
Genes 2024, 15(6), 785; https://doi.org/10.3390/genes15060785
Available online: https://www.mdpi.com/2073-4425/15/6/785
6. “Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine”
by Gideon T. Dosunmu and Ardaman Shergill
Genes 2024, 15(5), 538; https://doi.org/10.3390/genes15050538
Available online: https://www.mdpi.com/2073-4425/15/5/538
7. “Expansion of the Genotypic and Phenotypic Spectrum of ASH1L-Related Syndromic Neurodevelopmental Disorder”
by Ineke Cordova, Alyssa Blesson, Juliann M. Savatt, Abigail Sveden, Sonal Mahida, Heather Hazlett, Erin Rooney Riggs and Maya Chopra
Genes 2024, 15(4), 423; https://doi.org/10.3390/genes15040423
Available online: https://www.mdpi.com/2073-4425/15/4/423
8. “Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome”
by Doriana Misceo, Petter Strømme, Fatemeh Bitarafan, Maninder Singh Chawla, Ying Sheng, Sandra Monica Bach de Courtade, Lars Eide and Eirik Frengen
Genes 2024, 15(4), 500; https://doi.org/10.3390/genes15040500
Available online: https://www.mdpi.com/2073-4425/15/4/500
9. “Characteristics and Yield of Modern Approaches for the Diagnosis of Genetic Causes of Kidney Stone Disease”
by Andrea Spasiano, Mirko Treccani, Elisa De Tomi, Giovanni Malerba, Giovanni Gambaro and Pietro Manuel Ferraro
Genes 2024, 15(11), 1470; https://doi.org/10.3390/genes15111470
Available online: https://www.mdpi.com/2073-4425/15/11/1470
10. “PLEKHG1: New Potential Candidate Gene for Periventricular White Matter Abnormalities”
by Francesco Calì, Mirella Vinci, Simone Treccarichi, Carla Papa, Angelo Gloria, Antonino Musumeci, Concetta Federico, Girolamo Aurelio Vitello, Antonio Gennaro Nicotera, Gabriella Di Rosa et al.
Genes 2024, 15(8), 1096; https://doi.org/10.3390/genes15081096
Available online: https://www.mdpi.com/2073-4425/15/8/1096
If you are an active researcher in this field and are interested in publishing innovative research, please do not hesitate to contact the Managing Editor, Ms. Jessie Guo (jessie.guo@mdpi.com).
7 April 2026
Genes | Highly Cited Papers in 2024–2025 in the “Plant Genetics and Genomics” Section
The “Plant Genetics and Genomics” Section of Genes (ISSN: 2073-4425) is dedicated to publishing plant and algal genetics research, from molecular/functional characterization to evolutionary studies, covering gene regulation, epigenetics, chromatin organization, genetic engineering, and plastid genomics.
All papers are in an open-access format, granting our readers free and unlimited access to the full text of all the articles published in our journal. We welcome you to read our most highly cited papers published in 2024 and 2025, which are listed below.
1. “Advances in Understanding Fusarium graminearum: Genes Involved in the Regulation of Sexual Development, Pathogenesis, and Deoxynivalenol Biosynthesis”
by Gang Niu, Qing Yang, Yihui Liao, Daiyuan Sun, Zhe Tang, Guanghui Wang, Ming Xu, Chenfang Wang and Jiangang Kang
Genes 2024, 15(4), 475; https://doi.org/10.3390/genes15040475
Available online: https://www.mdpi.com/2073-4425/15/4/475
2. “A Sweet Potato MYB Transcription Factor IbMYB330 Enhances Tolerance to Drought and Salt Stress in Transgenic Tobacco”
by Chong Wang, Jian Lei, Xiaojie Jin, Shasha Chai, Chunhai Jiao, Xinsun Yang and Lianjun Wang
Genes 2024, 15(6), 693; https://doi.org/10.3390/genes15060693
Available online: https://www.mdpi.com/2073-4425/15/6/693
3. “Regulation of Oil Biosynthesis and Genetic Improvement in Plants: Advances and Prospects”
by Lixia Zhou, Qiufei Wu, Yaodong Yang, Qihong Li, Rui Li and Jianqiu Ye
Genes 2024, 15(9), 1125; https://doi.org/10.3390/genes15091125
Available online: https://www.mdpi.com/2073-4425/15/9/1125
4. “Chloroplast Genomes of Vitis flexuosa and Vitis amurensis: Molecular Structure, Phylogenetic, and Comparative Analyses for Wild Plant Conservation”
by Ji Eun Kim, Keyong Min Kim, Yang Su Kim, Gyu Young Chung, Sang Hoon Che and Chae Sun Na
Genes 2024, 15(6), 761; https://doi.org/10.3390/genes15060761
Available online: https://www.mdpi.com/2073-4425/15/6/761
5. “Progress in Rice Breeding Based on Genomic Research”
by Xingye Yang, Shicong Yu, Shen Yan, Hao Wang, Wei Fang, Yanqing Chen, Xiaoding Ma and Longzhi Han
Genes 2024, 15(5), 564; https://doi.org/10.3390/genes15050564
Available online: https://www.mdpi.com/2073-4425/15/5/564
6. “Insights into Phylogeny, Taxonomy, Origins and Evolution of Crataegus and Mespilus, Based on Comparative Chloroplast Genome Analysis”
by Jiaxin Meng, Yan Wang, Han Song, Wenxuan Dong and Ningguang Dong
Genes 2025, 16(2), 204; https://doi.org/10.3390/genes16020204
Available online: https://www.mdpi.com/2073-4425/16/2/204
7. “Hallmarks of DNA Damage Response in Germination Across Model and Crop Species”
by Federico Sincinelli, Shraddha Shridhar Gaonkar, Sri Amarnadh Gupta Tondepu, Conrado Jr Dueñas and Andrea Pagano
Genes 2025, 16(1), 95; https://doi.org/10.3390/genes16010095
Available online: https://www.mdpi.com/2073-4425/16/1/95
8. “Cross-Kingdom Communication via Plant-Derived Extracellular Vesicle Nucleic Acids in Genetically Engineered Nicotiana tabacum”
by Lorena Urbanelli, Federica Delo, Giada Cerrotti, Emidio Albertini, Jacopo Lucci, Sandra Buratta, Eleonora Calzoni, Stefano Giovagnoli, Luana Lugini, Cristina Federici et al.
Genes 2025, 16(3), 356; https://doi.org/10.3390/genes16030356
Available online: https://www.mdpi.com/2073-4425/16/3/356
9. “Genetic Diversity and Metabolic Profile of Tibetan Medicinal Plant Saussurea obvallata”
by Shengnan Zhang, Sujuan Wang, Shiyan Wang, Hao Su and Ji De
Genes 2025, 16(5), 593; https://doi.org/10.3390/genes16050593
Available online: https://www.mdpi.com/2073-4425/16/5/593
10. “Prime Editing for Crop Improvement: A Systematic Review of Optimization Strategies and Advanced Applications”
by Shuangrui Tian, Lan Yao, Yuhong Zhang, Xiaoyu Rao and Hongliang Zhu
Genes 2025, 16(8), 965; https://doi.org/10.3390/genes16080965
Available online: https://www.mdpi.com/2073-4425/16/8/965
If you are an active researcher in this field and are interested in publishing innovative research, please do not hesitate to contact the Managing Editor, Ms. Jessie Guo.





































